A single gene for human TRAF-3 at chromosome 14q32.3 encodes a variety of mRNA species by alternative polyadenylation, mRNA splicing and transcription initiation

Molecular Immunology

Volumn 35, Issue 18, 1998, Pages 1189-1206

  Van Eyndhoven, W G ^a   Frank, D ^a   Kalachikov, S ^b   Cleary, A M ^a   Hong, D I ^a   Cho, E ^a   Nasr, S ^a   Perez, A J ^a   Mackus, W J M ^a   Cayanis, E ^b   Wellington, S ^a,b   Fischer, S G ^b   Warburton, D ^a,b   Lederman, S ^a  

^a Columbia University ^*  (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Cell surface molecules; Human; Molecular biology; Signal transduction; T cell B cell collaboration

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 14; DNA SEQUENCE; GENE EXPRESSION; GENE LOCATION; GENE MAPPING; GENE STRUCTURE; MESSENGER RNA SYNTHESIS; NUCLEOTIDE SEQUENCE; POLYADENYLATION; PRIORITY JOURNAL; RNA ANALYSIS; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TRANSCRIPTION INITIATION;

ALTERNATIVE SPLICING; BASE COMPOSITION; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 14; CLONING, MOLECULAR; DNA, COMPLEMENTARY; EXONS; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTRONS; PHYSICAL CHROMOSOME MAPPING; PROTEINS; RNA, MESSENGER; TNF RECEPTOR-ASSOCIATED FACTOR 3; TRANSCRIPTION, GENETIC; UNTRANSLATED REGIONS; ZINC FINGERS;

EID: 0032469621     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(98)00099-6     Document Type: Article

References (81)

1. Aizawa, S., Nakano, H., Ishida, T., Horie, R., Nagai, M., Ito, K., Yagita, H., Okumura, K., Inoue, J., Watanabe, T., 1997. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFκB activation. J. Biol. Chem. 272, 2042-2045.
2. Ansieau, S., Scheffrahn, I., Mosialos, G., Brand, H., Duyster, J., Kaye, K., Harada, J., Dougall, B., Hubinger, G., Kieff, E., Herrmann, F., Leutz, A., Gruss, H.J., 1996. Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor κ B activation. Proc. Natl. Acad. Sci. U.S.A. 93, 14053-14058.
3. Arch, R.H., Thompson, C.B., 1998. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB. Mol. Cell Biol. 18, 558-565.
4. Boucher, L.M., Marengere, L.E., Lu, Y., Thukral, S., Mak, T.W., 1997. Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily. Biochem. Biophys. Res. Commun. 233, 592-600.
5. Breathnach, R., Chambon, P., 1981. Organization and expression of eucaryotic split genes coding for proteins. Annu. Rev. Biochem. 50, 349-383.
6. Brink, R., Lodish, H.F., 1998. Tumor necrosis factor receptor (TNFR)-associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domain that inhibits TNFR2-mediated NF-κB activation. J. Biol. Chem. 273, 4129-4134.
7. Callard, R.E., Smith, S.H., Herbert, J., Morgan, G., Padayachee, M., Lederman, S., Chess, L., Kroczek, R.A., Fanslow, W.C., Armitage, R.J., 1994. CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM). J. Immunol. 153, 3295-3306.
8. Castigli, E., Alt, F.W., Davidson, L., Bottaro, A., Mizoguchi, E., Bhan, A.K., Geha, R.S., 1994. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. U.S.A. 91, 12135-12139.
9. Chen, C.Y., Shyu, A.B., 1995. AU-rich elements: characterization and importance in mRNA degradation. [Review] [42 refs]. Trends. Biochem. Sci. 20, 465-470.
10. Chen, Z.Q., Hofker, M.H., Cox, D.W., 1995. Defining the breakpoint of a multigene deletion in the immunoglobulin heavy chain gene cluster. Immunogenetics 41, 69-73.
11. Cheng, G., Cleary, A.M., Ye, Z., Hong, D.I., Lederman, S., Baltimore, D., 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267, 1494-1497.
12. Cheng, G., Baltimore, D., 1996. TANK, a co-inducer with TRAF2 of TNF-and CD40L-mediated NF-κB activation. Genes Dev. 10, 963-973.
13. Conley, M.E., Larche, M., Bonagura, V.R., Lawton, A.R., Buckley, R., Fu, S.M., Coustan-Smith, E., Herrod, H.G., Campana, D., 1994. Hyper IgM syndrome associated with defective CD40-mediated B cell activation. J. Clin. Invest. 94, 1404-1409.
14. Cox, D.W., Billingsley, G.D., Bale, A.E., Donis-Keller, H., Edwards, J.H., Litt, M., Mcbride, W., Persichetti, F., Spurr, N.K., Weber, J.L., et al., 1995. CEPH consortium map of chromosome 14, Cytogenet. Cell Genet. 69, 175-178.
15. Cross, S.H., Bird, A.P., 1995. CpG islands and genes. Curr. Opin. Genet. Dev. 5, 309-314.
16. Devergne, O., Hatzivassiliou, E., Izumi, K.M., Kaye, K.M., Kleijnen, M.F., Kieff, E., Mosialos, G., 1996. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell Biol. 16, 7098-7108.
17. Duckett, C.S., Gedrich, R.W., Gilfillan, M.C., Thompson, C.B., 1997. Induction of nuclear factor κB by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol. Cell Biol. 17, 1535-1542.
18. Eliopoulos, A.G., Dawson, C.W., Mosialos, G., Floettmann, J.E., Rowe, M., Armitage, R.J., Dawson, J., Zapata, J.M., Kerr, D.J., Wakelam, M.J., Reed, J.C., Kieff, E., Young, L.S., 1996. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene 13, 2243-2254.
19. Force, W.R., Cheung, T.C., Ware, C.F. 1997. Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-β receptor. J. Biol. Chem. 272, 30835-30840.
20. Gardiner-Garden, M., Frommer, M., 1987. CpG islands in vertebrate genomes. J. Mol. Biol. 196, 261-282.
21. Gedrich, R.W., Gilfillan, M.C., Duckett, C.S., Van Dongen, J.L., Thompson, C.B., 1996. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J. Biol. Chem. 271, 12852-12858.
22. Han, J., Brown, T., Beutler, B., 1990. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171, 465-475.
23. Hanissian, S.H., Geha, R.S., 1997. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 6, 379-387.
24. Hayashi, Y., Pui, C.H., Behm, F.G., Fuchs, A.H., Raimondi, S.C., Kitchingman, G.R., Mirro, J. Jr., Williams, D.L., 1990. 14q32 translocations are associated with mixed-lineage expression in childhood acute leukemia. Blood 76, 150-156.
25. Hofker, M.H., Walter, M.A., Cox, D.W., 1989. Complete physical map of the human immunoglobulin heavy chain constant region gene complex. Proc. Natl. Acad. Sci. U.S.A. 86, 5567-5571.
26. Hofker, M.H., Smith, S., Nakamura, Y., Teshima, I., White, R., Cox, D.W., 1990. Physical mapping of probes within 14q32, a subtelomeric region showing a high recombination frequency. Genomics 6, 33-38.
27. Hu, H.M., O'Rourke, K., Boguski, M.S., Dixit, V.M., 1994. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269, 30069-30072.
28. Ishida, T., Mizushima, Si, Azuma, S., Kobayashi, N., Tojo, T., Suzuki, K., Aizawa, S., Watanabe, T., Mosialos, G., Kieff, E., Yamamoto, T., Inoue, J., 1996. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271, 28745-28748.
29. Ishida, T.K., Tojo, T., Aoki, T., Kobayashi, N., Ohishi, T., Watanabe, T., Yamamoto, T., Inoue, J., 1996. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. U.S.A. 93, 9437-9442.
30. Kang, H.K., Cox, D.W., 1996. Tandem repeats 3′ of the IGHA genes in the human immunoglobulin heavy chain gene cluster. Genomics 35, 189-195.
31. Kashiwada, M., Shirakata, Y., Inoue, J.I., Nakano, H., Okazaki, K., Okumura, K., Yamamoto, T., Nagaoka, H., Takemori, T., 1998. Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway. J. Exp. Med. 187, 237-244.
32. Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yosida, N., Kishimoto, T., Kikutani, H., 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167-178.
33. Kawamata, S., Hori, T., Imura, A., Takaori-Kondo, A., Uchiyama, T., 1998. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-κB activation. J. Biol. Chem. 273, 5808-5814.
34. Kim, S.J., Park K., Koeller, D., Kim, K.Y., Wakefield, L.M., Sporn, M.B., Roberts, A.B., 1992. Post-transcriptional regulation of the human transforming growth factor-β 1 gene. J. Biol. Chem. 267, 13702-13707.
35. Kozak, M., 1989a. Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs. Mol. Cell Biol. 9, 5134-5142.
36. Kozak, M., 1989b. The scanning model for translation: an update. J. Cell Biol. 108, 229-241.
37. Krajewski, S., Zapata, J.M., Krajewska, M., VanArsdale, T., Shabaik, A., Gascoyne, R.D., Reed, J.C., 1997. Immunohistochemical analysis of in vivo patterns of TRAF-3 expression, a member of the TNF receptor-associated factor family. J. Immunol. 159, 5841-5852.
38. Kruys, V., Wathelet, M., Poupart, P., Contreras, R., Fiers, W., Content, J., Huez, G., 1987. The 3′ untranslated region of the human interferon-β mRNA has an inhibitory effect on translation. Proc. Natl. Acad. Sci. U.S.A. 84, 6030-6034.
39. Lederman, S., Yellin, M.J., Inghirami, G., Lee, J.J., Knowles, D.M., Chess, L., 1992. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles: Roles of T-B Activating Molecule (5c8 Antigen) and CD40 in contact-dependent help. J. Immunol. 149, 3817-3826.
40. Lee, S.Y., Kandala, G., Liou, M.L., Liou, H.C., Choi, Y., 1996. CD30 TNF receptor-associated factor interaction: NF-κB activation and binding specificity. Proc. Natl. Acad. Sci. U.S.A. 93, 9699-9703.
41. Malinin, N.L., Boldin, M.P., Kovalenko, A.V., Wallach, D., 1997. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385, 540-544.
42. Maniatis, T., Fritsch, E.F., Sambook, S., 1982. Molecular cloning: A laboratory manual. Cold Spring Harbor, Cold Spring Harbor, NY.
43. Menon, A.G., Rutter, J.L., von Sattel, J.P., Synder, H., Murdoch, C., Blumenfeld, A., Martuza, R.L., von Deimling, A., Gusella, J, F., Houseal, T.W., 1997. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus. Oncogene 14, 611-616.
44. Morio, T., Hanissian, S., Geha, R.S., 1995. Characterization of a 23-kDa protein associated with CD40. Proc. Natl. Acad. Sci. U.S.A. 92, 11633-11636.
45. Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C., Kieff, E., 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389-399.
46. Motokura, T., Bloom, T., Kim, H.G., Juppner, H., Ruderman, J.V., Kronenberg, H.M., Arnold, A., 1991. A novel cyclin encoded by a bell-linked candidate oncogene. Nature 350, 512-515.
47. Nakano, H., Oshima, H., Chung, W., Williams-Abbott, L., Ware, C.F., Yagita, H., Okumura, K., 1996. TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin β receptor. J. Biol. Chem. 271, 14661-14664.
48. Nakano, H., Shindo, M., Yamada, K., Yoshida, M.C., Santee, S.M., Ware, C.F., Jenkins, N.A., Gilbert, D.J., Yagita, H., Copeland, N.C., Okumura, K., 1997. Human TNF receptor-associated factor 5 (TRAF5): cDNA cloning, expression and assignment of the TRAF5 gene to chromosome Iq32. Genomics 42, 26-32.
49. Neri, A., Chang, C.C., Lombardi, L., Salina, M., Corradini, P., Maiolo, A.T., Chaganti, R.S., Dalla-Favera, R., 1991. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κ B p50. Cell 67, 1075-1087.
50. Ohno, H., Takimoto, G., McKeithan, T.W., 1990. The candidate protooncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60, 991-997.
51. Parthasarathy, L., Parthasarathy, R., Vadnal, R., 1997. Molecular characterization of coding and untranslated regions of rat cortex lithium-sensitive myo-inositol monophosphatase cDNA. Gene 191, 81-87.
52. Regnier, C.H., Tomasetto, C., Moog-Lutz, C., Chenard, M.P., Wendling, C., Basset, P., Rio, M.C., 1995. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J. Biol. Chem. 270, 25715-25721.
53. Regnier, C.H., Song, H.Y., Gao, X., Goeddel, D.V., Cao, Z., Rothe, M., 1997. Identification and characterization of an IκB kinase. Cell 90, 373-383.
54. Renshaw, B.R., Fanslow, W.C., 3rd, Armitage, R.J., Campbell, K.A., Liggitt, D., Wright, B., Davison, B.L., Maliszewski, C.R., 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180, 1889-1900.
55. Romeo, D.S., Park, K., Roberts, A.B., Sporn, M.B., Kim, S.J., 1993. An element of the transforming growth factor-β 1 5′-untranslated region represses translation and specifically binds a cytosolic factor. Mol. Endocrinol. 7, 759-766.
56. Rothe, M., Wong, S.C., Henzel, W.J., Goeddel, D.V., 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681-692,
57. Rothe, M., Sarma, V., Dixit, V.M., Goeddel, D.V., 1995. TRAF2-mediated activation of NFκ-B by TNF Receptor 2 and CD40. Science 269, 1424-1427.
58. Rothe, M., Xiong, J., Shu, H.B., Williamson, K., Goddard, A., Goeddel, D.V., 1996. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc. Natl. Acad. Sci. U.S.A. 93, 8241-8246.
59. Sato, T., Irie, S., Reed, J.C., 1995. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Letters 358, 113-118.
60. Schullerus, D., Herbers, J., Chudek, J., Kanamaru, H., Kovacs, G., 1997. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas. J. Pathol. 183, 151-155.
61. Schwerdtle, R.F., Winterpacht, A., Storkel, S., Brenner, W., Hohenfellner, R., Zabel, B., Huber, C., Decker, H.J., 1997. Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas. Cancer Res. 57, 5009-5012.
62. Shaw, G., Kamen, R., 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46, 659-667.
63. Siegel, J.P., Mostowski, H.S., 1990. A bioassay for the measurement of human interleukin-4. J. Immunol. Methods 132, 287-295.
64. Siemienski, K., Peters, N., Scheurich, P., Wajant, H., 1997. Organization of the human tumour necrosis factor receptor-associated factor 1 (TRAF1) gene and mapping to chromosome 9q33-34. Gene 195, 35-39.
65. Simon, M., von Deimling, A., Larson, J.J., Wellenreuther, R., Kaskel, P., Waha, A., Warnick, R.E., Tew, J.M., Jr., Menon, A.G., 1995. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res. 55, 4696-4701.
66. Song, H.Y., Regnier, C.H., Kirschning, C.J., Goeddel, D.V., Rothe, M., 1997. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. U.S.A. 94, 9792-9796.
67. Takeuchi, M., Rothe, M., Goeddel, D.V., 1996. Anatomy of TRAF2. Distinct domains for nuclear factor-κB activation and association with tumor necrosis factor signaling proteins. J. Biol. Chem. 271, 19935-19942.
68. Taub, R., Kirsch, I., Morton, C., Lenoir, G., Swan, D., Tronick, S., Aaronson, S., Leder, P., 1982. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc. Natl. Acad. Sci. U.S.A. 79, 7837-7841.
69. Tse, J.Y., Ng, H.K., Lau, K.M., Lo, K.W., Poon, W.S., Huang, D.P., 1997. Loss of heterozygosity of chromosome 14q in low-and high-grade meningiomas. Hum. Pathol. 28, 779-785.
70. Tsujimoto, Y., Finger, L.R., Yunis, J., Nowell, P.C., Croce, C.M., 1984. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226, 1097-1099.
71. Vanarsdale, T.L., VanArsdale, S.L., Force, W.R., Walter, B.N., Mosialos, G., Kieff, E., Reed, J.C., Ware, C.F., 1997. Lymphotoxin-β receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor κB. Proc. Natl. Acad. Sci. U.S.A. 94, 2460-2465.
72. Wang, X., Bornslaeger, E.A., Haub O., Tomihara-Newberger, C., Lonberg, N., Dinulos, M.B., Disteche, C.M., Copeland, N., Gilbert, D.J., Jenkins, N.A., Lacy, E., 1996. A candidate gene for the amnionless gastrulation stage mouse mutation encodes a TRAF-related protein. Dev. Biol. 177, 274-290.
73. Wenger, R.H., Rolfs, A., Spielmann, P., Zimmermann, D.R., Gassmann M., 1998. Mouse hypoxia-inducible factor-1 α is encoded by two different mRNA isoforms: expression from a tissue-specific and a housekeeping-type promoter. Blood 91, 3471-3480.
74. Wilson, T., Treisman, R., 1988. Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3′ AU-rich sequences. Nature 336, 396-399.
75. Wiman, K.G., Clarkson, B., Hayday, A.C., Saito, H., Tonegawa, S., Hayward, W.S., 1984. Activation of a translocated c-myc gene: role of structural alterations in the upstream region. Proc. Natl. Acad Sci. U.S.A. 81, 6798-6802.
76. Wintle, R.F., Nygaard, T.G., Herbrick, J.A., Kvaloy, K., Cox, D.W., 1997. Genetic polymorphism and recombination in the subtelomeric region of chromosome 14q. Genomics 40, 409-414.
77. Xu, J., Foy, T.M., Laman, J.D., Elliott, E.A., Dunn, J.J., Waldschmidt, T.J., Elsemore, J., Noelle, R.J., Flavell, R.A., 1994. Mice deficient for the CD40 ligand. Immunity 1, 423-431.
78. Xu, Y., Cheng, G., Baltimore, D., 1996. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity 5, 407-415.
79. Ye, B.H., Lista, F., Lo Coco, F., Knowles, D.M., Offit, K., Chaganti, R.S., Dalla-Favera, R., 1993. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262, 747-750.
80. Yellin, M.J., Lee, J.J., Chess, L., Lederman, S., 1991. A human CD4-leukemic subclone with contact dependent helper function. J. Immunol. 147, 3389-3395.
81. Yu, F., Warburton, D., Wellington, S., Danziger, R.S., 1996. Assignment of GUCIA2, the gene coding for the α 2 subunit of soluble guanylyl cyclase, to position 11q21-q22 on human chromosome 11. Genomics 33, 334-336.